LUCD
Lucid Diagnostics Inc
NASDAQ: LUCD · HEALTHCARE · MEDICAL DEVICES
$1.07
+3.88% today
Updated 2026-04-30
Market cap
$199.66M
P/E ratio
—
P/S ratio
42.43x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
Lucid Diagnostics Inc (LUCD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $17800.00 | $1.03M | $2.19M | $59.00M | $32.51M | $27.27M | $30.71M |
| Cash & equivalents | $17800.00 | $156404.00 | $111000.00 | $53.66M | $22.47M | $18.90M | $22.36M |
| Current assets | $17800.00 | $390900.00 | $1.44M | $57.30M | $24.36M | $22.07M | $25.15M |
| Total liabilities | $1.08M | $6.34M | $15.71M | $4.26M | $9.46M | $29.58M | $25.32M |
| Current liabilities | $1.08M | $6.34M | $15.71M | $4.26M | $8.43M | $29.38M | $23.52M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $-1.06M | $-5.31M | $-13.52M | $54.74M | $23.05M | $-2.31M | $5.39M |
| Retained earnings | $-1.13M | $-5.55M | $-13.83M | $-41.90M | $-98.08M | $-150.74M | $-203.77M |
| Accounts receivable | — | — | $1.00 | $200000.00 | $17000.00 | $45000.00 | $405000.00 |
| Inventory | — | $0.00 | $834000.00 | $493000.00 | $111000.00 | $278000.00 | $341000.00 |
| Goodwill | — | — | — | — | — | — | $735.26M |